EPA-话题@MedSci

#EPA#

1120篇内容 | 5282人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1427355, encodeId=83a2142e3557e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology：肝静脉压梯度对肝硬化择期手术患者预后的预测作用, objectType=article, longId=181628, objectId=1c1a181628b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c1a181628b2, replyNumber=0, likeNumber=77, createdTime=2019-10-21, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c1a181628b2, moduleTitle=J Hepatology：肝静脉压梯度对肝硬化择期手术患者预后的预测作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c1a181628b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427354, encodeId=b125142e35411, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：辛伐他汀联合利福昔明用于失代偿期肝硬化患者安全性研究, objectType=article, longId=180995, objectId=993d1809954a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=993d1809954a, replyNumber=0, likeNumber=71, createdTime=2019-10-13, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=993d1809954a, moduleTitle=Lancet Gastroen Hepatol：辛伐他汀联合利福昔明用于失代偿期肝硬化患者安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=993d1809954a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427353, encodeId=ddfc142e3539a, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Gastroen Hepatol：克罗恩病肉芽肿患者的临床特征, objectType=article, longId=180200, objectId=617c18020029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=617c18020029, replyNumber=0, likeNumber=99, createdTime=2019-09-30, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=617c18020029, moduleTitle=J Gastroen Hepatol：克罗恩病肉芽肿患者的临床特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=617c18020029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427352, encodeId=4293142e35203, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology：普伐他汀与索拉非尼联合治疗并未改善晚期肝细胞癌的生存率, objectType=article, longId=179354, objectId=69551e93547e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69551e93547e, replyNumber=0, likeNumber=78, createdTime=2019-09-14, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69551e93547e, moduleTitle=J Hepatology：普伐他汀与索拉非尼联合治疗并未改善晚期肝细胞癌的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69551e93547e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427351, encodeId=e13d142e35195, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology：恩替卡韦与替诺福韦治疗慢性乙型肝炎的疗效分析, objectType=article, longId=179352, objectId=ef901e935215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef901e935215, replyNumber=0, likeNumber=69, createdTime=2019-09-14, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef901e935215, moduleTitle=J Hepatology：恩替卡韦与替诺福韦治疗慢性乙型肝炎的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef901e935215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427350, encodeId=8aa9142e350a6, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：阿司匹林肿瘤辅助治疗的安全性评估, objectType=article, longId=178656, objectId=fd311e865633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd311e865633, replyNumber=0, likeNumber=126, createdTime=2019-09-04, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd311e865633, moduleTitle=Lancet Gastroen Hepatol：阿司匹林肿瘤辅助治疗的安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd311e865633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427349, encodeId=10de142e34909, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Circulation：单用EPA或联合DHA均可有效降低高甘油三酯, objectType=article, longId=178022, objectId=1c171e8022fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c171e8022fe, replyNumber=0, likeNumber=99, createdTime=2019-08-22, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c171e8022fe, moduleTitle=Circulation：单用EPA或联合DHA均可有效降低高甘油三酯, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c171e8022fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427348, encodeId=8972142e348b1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：酒精摄入对非酒精性脂肪性肝病患者死亡率的影响, objectType=article, longId=177867, objectId=ae961e786707, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae961e786707, replyNumber=0, likeNumber=101, createdTime=2019-08-19, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae961e786707, moduleTitle=Hepatology：酒精摄入对非酒精性脂肪性肝病患者死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae961e786707)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427347, encodeId=8805142e34722, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：质子泵抑制剂会导致肝硬化患者的肝性脑病发生率和死亡率增加, objectType=article, longId=177865, objectId=f6d91e78654f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6d91e78654f, replyNumber=0, likeNumber=142, createdTime=2019-08-19, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6d91e78654f, moduleTitle=Hepatology：质子泵抑制剂会导致肝硬化患者的肝性脑病发生率和死亡率增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6d91e78654f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427346, encodeId=1d75142e3465f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：奥沙利铂辅助温热腹腔内化疗与结肠癌患者转移风险, objectType=article, longId=176643, objectId=be451e6643f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be451e6643f4, replyNumber=0, likeNumber=94, createdTime=2019-08-03, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be451e6643f4, moduleTitle=Lancet Gastroen Hepatol：奥沙利铂辅助温热腹腔内化疗与结肠癌患者转移风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be451e6643f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427345, encodeId=709d142e3457e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=NAT REV GASTRO HEPAT：病毒性肝炎诊断过晚或引起可怕后果, objectType=article, longId=176426, objectId=37371e6426b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37371e6426b4, replyNumber=0, likeNumber=115, createdTime=2019-07-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37371e6426b4, moduleTitle=NAT REV GASTRO HEPAT：病毒性肝炎诊断过晚或引起可怕后果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37371e6426b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427344, encodeId=3104142e34466, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：全球流行病学调查：2型糖尿病患者中的NAFLD和NASH——系统评价和荟萃分析, objectType=article, longId=176270, objectId=2bed1e627012, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bed1e627012, replyNumber=0, likeNumber=110, createdTime=2019-07-28, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bed1e627012, moduleTitle=J Hepatol：全球流行病学调查：2型糖尿病患者中的NAFLD和NASH——系统评价和荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bed1e627012)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427343, encodeId=d5ac142e343f2, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：证实马兜铃酸导致肝癌, objectType=article, longId=176121, objectId=6fb31e612125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fb31e612125, replyNumber=0, likeNumber=83, createdTime=2019-07-26, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fb31e612125, moduleTitle=Hepatology：证实马兜铃酸导致肝癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fb31e612125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427342, encodeId=9d4b142e3424e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：去甲熊去氧胆酸降低非酒精性脂肪性肝病患血清ALT, objectType=article, longId=176067, objectId=050f1e6067e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=050f1e6067e3, replyNumber=0, likeNumber=86, createdTime=2019-07-25, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=050f1e6067e3, moduleTitle=Lancet Gastroen Hepatol：去甲熊去氧胆酸降低非酒精性脂肪性肝病患血清ALT, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=050f1e6067e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427341, encodeId=1cf7142e341fa, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：急慢性肝功能衰竭3级患者比肝移植（LT）状态1a患者14天等待死亡率更高, objectType=article, longId=176006, objectId=4cdb1e60060d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cdb1e60060d, replyNumber=0, likeNumber=97, createdTime=2019-07-24, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cdb1e60060d, moduleTitle=Hepatology：急慢性肝功能衰竭3级患者比肝移植（LT）状态1a患者14天等待死亡率更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cdb1e60060d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427340, encodeId=140c142e340b8, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：小密度低密度脂蛋白胆固醇可以预测肝移植受者的心血管事件发生情况, objectType=article, longId=176005, objectId=eb801e6005fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb801e6005fe, replyNumber=0, likeNumber=84, createdTime=2019-07-24, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb801e6005fe, moduleTitle=Hepatology：小密度低密度脂蛋白胆固醇可以预测肝移植受者的心血管事件发生情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb801e6005fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427339, encodeId=72ff142e339bb, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：血清金属水平与胆结石和胆囊癌发生关系, objectType=article, longId=176004, objectId=b4181e60043a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4181e60043a, replyNumber=0, likeNumber=90, createdTime=2019-07-24, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4181e60043a, moduleTitle=Hepatology：血清金属水平与胆结石和胆囊癌发生关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4181e60043a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427338, encodeId=39c2142e3387c, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率, objectType=article, longId=176003, objectId=fb721e600347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb721e600347, replyNumber=0, likeNumber=81, createdTime=2019-07-24, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb721e600347, moduleTitle=J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb721e600347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427337, encodeId=ebc4142e337f6, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=细菌性肺炎治疗遭遇挫折：已停止Murepavadin静脉注射制剂的III期PRISM研究, objectType=article, longId=175764, objectId=783b1e5764e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=783b1e5764e6, replyNumber=0, likeNumber=87, createdTime=2019-07-20, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=783b1e5764e6, moduleTitle=细菌性肺炎治疗遭遇挫折：已停止Murepavadin静脉注射制剂的III期PRISM研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=783b1e5764e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427336, encodeId=acd2142e33615, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet：Rimegepant崩解片治疗偏头痛, objectType=article, longId=175422, objectId=63c51e542275, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63c51e542275, replyNumber=0, likeNumber=82, createdTime=2019-07-16, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63c51e542275, moduleTitle=Lancet：Rimegepant崩解片治疗偏头痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63c51e542275)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EPA

2020-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology：肝静脉压梯度对肝硬化择期手术患者预后的预测作用

2019-10-21

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：辛伐他汀联合利福昔明用于失代偿期肝硬化患者安全性研究

2019-10-13

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Gastroen Hepatol：克罗恩病肉芽肿患者的临床特征

2019-09-30

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology：普伐他汀与索拉非尼联合治疗并未改善晚期肝细胞癌的生存率

2019-09-14

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology：恩替卡韦与替诺福韦治疗慢性乙型肝炎的疗效分析

2019-09-14

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：阿司匹林肿瘤辅助治疗的安全性评估

2019-09-04

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Circulation：单用EPA或联合DHA均可有效降低高甘油三酯

2019-08-22

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：酒精摄入对非酒精性脂肪性肝病患者死亡率的影响

2019-08-19

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：质子泵抑制剂会导致肝硬化患者的肝性脑病发生率和死亡率增加

2019-08-19

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：奥沙利铂辅助温热腹腔内化疗与结肠癌患者转移风险

2019-08-03

gwc384 (审核中...)

前往app查看评论内容

#EPA#

NAT REV GASTRO HEPAT：病毒性肝炎诊断过晚或引起可怕后果

2019-07-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：全球流行病学调查：2型糖尿病患者中的NAFLD和NASH——系统评价和荟萃分析

2019-07-28

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：证实马兜铃酸导致肝癌

2019-07-26

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：去甲熊去氧胆酸降低非酒精性脂肪性肝病患血清ALT

2019-07-25

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：急慢性肝功能衰竭3级患者比肝移植（LT）状态1a患者14天等待死亡率更高

2019-07-24

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：小密度低密度脂蛋白胆固醇可以预测肝移植受者的心血管事件发生情况

2019-07-24

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：血清金属水平与胆结石和胆囊癌发生关系

2019-07-24

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率

2019-07-24

gwc384 (审核中...)

前往app查看评论内容

#EPA#

细菌性肺炎治疗遭遇挫折：已停止Murepavadin静脉注射制剂的III期PRISM研究

2019-07-20

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet：Rimegepant崩解片治疗偏头痛

2019-07-16

科室
- - 订阅+
  - 更多科室
工具
服务